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Abstract
Background: Spontaneous bacterial peritonitis (SBP) is common in hospitalized cirrhotic patients with ascites and carries high mortality. This study aimed to determine
whether early diagnostic paracentesis (EDP) <12 h of hospitalization conveys an
intermediate-term (6-month) survival beneﬁt in cirrhotic patients diagnosed with SBP.
Methods: Consecutive US veterans with cirrhosis diagnosed with SBP over 13 years
at a single VA medical center were reviewed retrospectively. Kaplan-Meyer analyses
assessed the effects of EDP on survival.
Results: A total of 79 cirrhotic patients were diagnosed with SBP (61.8  8.8 years,
n = 77 male, n = 52 [66.8%] Caucasian, n = 23 [29.1%] African-American). Underlying liver diseases included hepatitis c viral infection (HCV) (17.5%), alcohol (28.6%),
alcohol and HCV (30.1%), and cryptogenic/metabolic (15.9%). Median baseline
model for end-stage liver disease (MELD) was 12 (range 6–34), and median MELD
at presentation was 18. Seven subjects had a history of hepatocellular carcinoma
(11.1%), and 26 (41.3%) presented with sepsis. Thirty-three (52.4%) subjects died
within 6 months after the SBP admission. Of the subjects, 41 (65.1%) underwent
EDP, of which 23 (56.0%) survived at least 6 months, compared to only 7 of the
22 patients (31.8%) undergoing paracentesis >12 h from presentation (P = 0.057).
The maximal beneﬁt of EDP on survival was observed beyond days 14 and 30; at
these time points, no statistical difference in mortality was discernable (P = 0.55 and
0.71). In a multivariate model including age, MELD at admission, hepatocellular cancer, and sepsis criteria, EDP (p 0.034) positively impacted patient survival at
6 months.
Conclusions: EDP is associated with improved 6-month mortality in cirrhotic patients
with ascites. In this veteran cohort, EDP was as important as MELD as a predictor of
intermediate-term survival.

Introduction
Spontaneous bacterial peritonitis (SBP) is a signiﬁcant source of
morbidity and mortality in hospitalized patients with cirrhosis
and ascites.1 While studies have shown a low SBP prevalence
(3.5%) for asymptomatic cirrhotics in the outpatient setting, this
number rises to 11–29% for those admitted to the hospital for
any reason.2 In acknowledgement of the subtle, often-insidious
course that characterizes early stages of SBP, current practice
guidelines recommend diagnostic paracentesis in all patients with
ascites admitted for management of complications of cirrhosis.3–5
Nonetheless, the potential to improve clinical outcomes
through early paracentesis has not been fully explored. A recent
retrospective study of a large national database concluded that
patients with paracentesis performed on the day of admission or

the following day were observed to have a lower mortality rate
(5.5 vs 7.4%, odds ratio [OR] 1.11, 95% conﬁdence interval
[CI] = 0.96–1.28) compared to those who underwent paracentesis
later in the course of their stay.6 Another retrospective study
from two tertiary care centers demonstrated higher rates of inhouse mortality (adjusted OR 2.7, 95% CI = 1.3–4.8) among
patients receiving delayed paracentesis, deﬁned as later than 12 h
from presentation.7 This, along with model for end-stage liver
disease (MELD) scores, has been shown to be a signiﬁcant predictor of mortality in hospitalized patients.8,9
Like many medical centers, our facility does not have a
protocol in place to perform paracentesis in patients admitted
with cirrhosis and ascites. This retrospective analysis was thus
performed to determine whether the timing of paracentesis is
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associated with increased morbidity and mortality in patients
admitted with cirrhosis-related complications.

Methods
Study subjects. A retrospective cohort study of consecutive
US veterans, ages 20–80 years, with cirrhosis and a diagnosis of
SBP during hospitalization over a 13-year period (1 July 2005 to
1 July 2018) was performed at this single VA Medical Center.
Inclusion criteria were: (i) diagnosis of cirrhosis by ICD-9 and
ICD-10 codes or index history and physical exam (H&P) note,
with ascites noted on index H&P exam; (ii) SBP based on peritoneal ﬂuid analysis (ascitic ﬂuid absolute neutrophil count [ANC]
of ≥250 cells per mm3)3,10; and (iii) admission for cirrhosisrelated complications (bleed, encephalopathy, worsening ascites,
liver mass, or portal vein thrombosis)11 or nonspeciﬁc symptoms,
including fever, tachycardia, leukocytosis, and hypotension.
Exclusion criteria included: (i) admission for a noncirrhosisrelated etiology (e.g. scheduled admission for elective surgical
procedures); (ii) documentation of a bedside ultrasound without
appreciable ascites to attempt for drainage; and (iii) emergent
surgery or patient demise precluding attempt at paracentesis
within the ﬁrst day of presentation.
Medical records were reviewed to determine baseline characteristics, including age, gender, race/ethnicity, body mass index
(BMI), etiology of chronic liver disease (including alcohol, viral
Hepatitis B/C, or other metabolic, genetic, autoimmune causes),
use of SBP prophylaxis before hospitalization, and other complications of cirrhosis at presentation (hepatocellular carcinoma
[HCC], renal dysfunction, etc.). Clinical diagnosis of “sepsis” as
listed in the medical record or Sequential (Sepsis-related) Organ
Failure Assessment (SOFA) score of ≥2 were documented.12
MELD scores at the time of admission were calculated. Time
from admission to paracentesis was recorded, as was administration of albumin and antibiotics. Early diagnostic paracentesis
(EDP) was deﬁned as the performance of the paracentesis within
12 h of presentation; those undergoing paracentesis >12 h
postadmission were categorized in the late diagnostic
paracentesis (LDP) group. Data on patient mortality were collected up to 6 months beyond the index hospital admission.

Statistical analysis. Grouped values are reported as
mean  standard deviation unless otherwise indicated. Betweengroup comparisons were performed using Student’s t-tests, and
chi-square analyses were performed for binomial data. Nonparametric testing using independent sample median tests were performed to assess between-group differences in central tendency
for variables with non-Gaussian distribution.
Six-month survival following SBP admission was
implemented, and Kaplan-Meyer analyses assessed the effects
of EDP (≤12 h from presentation) on survival, with generation
of survival plots. Logistic regression models were used to control for potentially relevant clinical and demographic factors.
Patient factors identiﬁed as signiﬁcant in univariate analysis
were implemented in a ﬁnal multivariate Cox proportional hazards model. In each case, P < 0.05 was required for statistical
signiﬁcance.
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Results
Demographics and baseline clinical characteristics. A total of 79 cirrhotic patients (61.8  8.8 years, n = 77
male, n = 52 [66.8%] Caucasian, n = 23 [29.1%] African-American) had documentation of SBP following admission to the Saint
Louis Veterans Administration Medical Center (STLVAMC)
during the study period. Of these patients, 16 were excluded
from further analysis due to the performance of a diagnostic
paracentesis prior to presentation. Of the remaining 63 cirrhotic
patients, 32 (65.1%) underwent an early diagnostic paracentesis.
The demographic features and baseline clinical characteristics of
these patients are reported in Table 1. Those who underwent
EDP were younger (P = 0.039) and trended toward having lower
rates of chronic kidney disease (P = 0.055). There were no signiﬁcant differences in baseline MELD, the etiology underlying
chronic liver disease, malignancy diagnoses, or medication regimens between the EDP and LDP groups.
Presenting clinical characteristics. The median time to
paracentesis was 5 h in the EDP group, compared to 42 h in the
LDP cohort (Table 2). There were no signiﬁcant differences in
presenting MELD in the EDP and LDP subgroups (17.2 vs 18.6,
P = 0.47), although a higher percentage of the LDP group (45.5
Table 1

Baseline patient demographics and clinical characteristics
Early diagnostic Late diagnostic
paracentesis
paracentesis
(n = 41)
(n = 22)
P value

Age, years (mean  SD)
Male, n (%)
Race, n (%)
Caucasian
African-American
Other
Body mass index, kg/m2
(mean  SD)
Cirrhosis etiology, n (%)
Hepatitis C
Alcohol
Hepatitis C and alcohol
Cryptogenic
Non-alcoholic
steatohepatitis
Hepatitis B
Medical comorbidities, n (%)
Any malignancy
Hepatocellular carcinoma
Chronic kidney disease
Baseline serum creatinine,
mg/dL (mean  SD)
Baseline MELD score
(mean  SD)
Medication regimen, n (%)
Diuretics
Prophylactic antibiotics
Proton pump inhibitor

60.3  7.0
39 (95.1)

65.9  11.1
22 (100)

26 (63.4)
12 (29.3)
3 (7.3)
29.6  6.9

16 (72.7)
6 (27.3)
0 (0)
28.6  7.7

8 (19.5)
13 (31.7)
13 (31.7)
4 (9.8)
3 (7.3)

3 (13.6)
5 (22.7)
6 (27.3)
6 (27.3)
1 (4.5)

0 (0)

1 (4.5)

8 (19.5)
4 (9.8)
3 (7.3)
0.93  0.43

4 (18.2)
3 (13.6)
6 (27.3)
1.22  0.64

0.89
0.69
0.055
0.07

17.2  6.6

18.5  7.0

0.48

30 (73.2)
6 (14.6)
18 (43.9)

13 (59.1)
1 (4.5)
6 (27.3)

0.25
0.41
0.20

0.039
0.29

0.40
0.63

0.34

MELD, model for end-stage liver disease; SD, standard deviation.
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Table 2 Presenting patient clinical characteristics and outcomes
Early diagnostic Late diagnostic
paracentesis
paracentesis
(n = 22)
P value
(n = 41)
Time to paracentesis, hours,
median (range)
Admission laboratories
Serum creatinine (Scr),
mg/dL (mean  SD)
Acute kidney injury,† n (%)
MELD score (mean  SD)
Leukocyte count, cells/mL
(mean  SD)
Serum sodium, mEq/L
(mean  SD)
Sepsis,‡ n (%)
Medications provided at
admission, n (%)
Albumin
Diuretics
Death, 6 months, n (%)
Median time to death,
days (range)

5 (0–12)

42 (13–192)

<0.001

1.37  1.15

1.84  1.27

0.15

7 (17.1)
17.2  6.6
11.0  7.9

10 (45.5)
18.6  7.0
10.4  5.6

0.02
0.47
0.75

132.0  6.1

133.8  4,9

0.23

18 (43.9)

8 (36.4)

0.69

32 (78.0)
30 (69.8)
18 (43.9)
46 (3–175)

14 (63.6)
13 (30.2)
15 (68.2)
11 (1–131)

0.22
0.25
0.057
0.079

†

Acute kidney injury deﬁned as an increase in serum creatinine of ≥0.5
over baseline.
‡
Sepsis deﬁned as a documented clinical diagnosis of “sepsis” or a
Sequential (Sepsis-related) Organ Failure Assessment score of ≥2.
MELD, model for end-stage liver disease; SD, standard deviation.

vs 17.1%, P = 0.02) presented with acute kidney injury. Furthermore, there were no signiﬁcant differences in leukocyte count,
clinical evidence of sepsis, or medication regimens administered
(antibiotics, albumin, and diuretics) between the paracentesis
subgroups.

Outcomes. Overall, 33 (52.4%) of the study patients died
within 6 months of the index SBP admission. Fewer patients
undergoing EDP died during follow up (18/41, 43.9%) compared to the LDP group (15/22, 68.2%; P = 0.057). The
median time to death was also considerably lower in the EDP
group (46 vs 11 days, P = 0.079). The survival plot of the
EDP and LDP groups is displayed in Figure 1. The survival
beneﬁt of EDP was discernible shortly after admission, with
14-day mortality rates in patients who underwent LDP, more
than twice as high as the EDP group (6/22, 27.3% vs 5/41,
12.2%, P = 0.13).

Predictors of patient survival. A multivariate Cox Proportional Hazard model examining 6-month mortality by timing
of paracentesis was generated (Table 3). Controlling for age,
race, and signiﬁcant medical comorbidities (malignancy, sepsis
evidence, and acute kidney injury) and use of prophylactic antibiotics, patients who underwent EDP had a nearly 60% reduction
in 6-month mortality compared to their LDP counterparts (Exp
(B) 0.42, 95% CI 0.188–0.938, P = 0.034).

Figure 1 Survival plot of the early diagnostic paracentesis (EDP) and late
diagnostic paracentesis (LDP) groups. SBP, spontaneous bacterial peritonitis.
(
) LDP, (
) EDP, (
) LDP-censored, (
) EDP-censored.

Discussion
In this study of a single Veterans Affairs Hospital experience of
consecutive cirrhotic patients hospitalized with an eventual diagnosis of SBP, we found a statistically signiﬁcant survival beneﬁt
in those patients who underwent early diagnostic paracentesis.
This improvement in mortality rate was borne out as far as
6 months beyond the time of presentation, and it held true after
controlling for multiple clinical and demographic factors.
This study is consistent with previously performed studies showing the importance of the diagnostic paracentesis in
any patient who is hospitalized with decompensated cirrhosis
and a tangible amount of ascites. Our ﬁndings also are consistent with prior studies showing that earlier paracentesis trends
toward a beneﬁt in mortality. Orman and colleagues noted, in
a large 2016 study of 17 500 cirrhotic patients, that delays in
the performance of paracentesis (>1 day or 24 h) after admission resulted in a higher in-hospital mortality, although this
observation did not remain signiﬁcant in a multivariate analysis.13 Similarly, in a 2016 study by Gaetano et al., there was a
trend toward reduction in inpatient mortality among cirrhotic
patients undergoing earlier paracentesis.6 Another study of
nosocomial SBP observed that mortality impact was sustained
through 90 days, even after the initial SBP episode had
resolved.14 Our study additionally suggests that the mortality
beneﬁt of EDP may extend up to 6 months beyond the index
SBP diagnosis.
Our study is bolstered by the robust nature of the VA Corporate Data Warehouse database, allowing for thorough and standardized collection of clinical and demographic data, as well as a
full, time-sensitive account of diagnostic testing, administered
therapies, and outcomes.15 From a demographic perspective, the
racially diverse makeup of the examined VA center resulted in a
strong African American representation in this study. Limitations
of the study include its selection bias toward males, alcoholics,
and those with hepatitis C—a quality inherent to all VA-based
population studies on cirrhosis.16 Furthermore, this study was
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Table 3 Cox proportional hazard model predicting patient mortality
within 6 months of diagnosed spontaneous bacterial peritonitis

of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;
57: 1651–3.
Kanwal F, Kramer J, Asch SM et al. An explicit quality indicator set
for measurement of quality of care in patients with cirrhosis. Clin.
Gastroenterol. Hepatol. 2010; 8: 709–17.
European Association for the Study of the L. EASL clinical practice
guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol. 2010; 53:
397–417.
Gaetano JN, Micic D, Aronsohn A et al. The beneﬁt of paracentesis
on hospitalized adults with cirrhosis and ascites. J. Gastroenterol.
Hepatol. 2016; 31: 1025–30.
Kim JJ, Tsukamoto MM, Mathur AK et al. Delayed paracentesis is
associated with increased in-hospital mortality in patients with
spontaneous bacterial peritonitis. Am. J. Gastroenterol. 2014; 109:
1436–42.
Nobre SR, Cabral JE, Gomes JJ, Leitao MC. In-hospital mortality in
spontaneous bacterial peritonitis: a new predictive model. Eur.
J. Gastroenterol. Hepatol. 2008; 20: 1176–81.
Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33:
464–70.
Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites. World J. Gastroenterol. 2019;
25: 3738–52.
Lo Re V 3rd, Lim JK, Goetz MB et al. Validity of diagnostic
codes and liver-related laboratory abnormalities to identify hepatic
decompensation events in the Veterans Aging Cohort Study.
Pharmacoepidemiol. Drug Saf. 2011; 20: 689–99.
Vincent JL, de Mendonca A, Cantraine F et al. Use of the SOFA
score to assess the incidence of organ dysfunction/failure in intensive
care units: results of a multicenter, prospective study. Working group
on "sepsis-related problems" of the European Society of Intensive
Care Medicine. Crit. Care Med. 1998; 26: 1793–800.
Orman ES, Hayashi PH, Bataller R, Barritt AS. Paracentesis is
associated with reduced mortality in patients hospitalized with
cirrhosis and ascites. Clin. Gastroenterol. Hepatol. 2014; 12:
496–503 e1.
Kimmann M, Tergast TL, Schultalbers M et al. Sustained impact of
nosocomial-acquired spontaneous bacterial peritonitis in different
stages of decompensated liver cirrhosis. PLoS One. 2019; 14:
e0220666.
Kaplan DE, Dai F, Aytaman A et al. Development and performance
of an algorithm to estimate the child-turcotte-pugh score from a
national electronic healthcare database. Clin. Gastroenterol. Hepatol.
2015; 13: 2333–41.e1-6.
Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D,
Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001–2013. Gastroenterology. 2015; 149: 1471–82.e5; quiz e17-8.
Chinnock B, Hendey GW, Minnigan H, Butler J, Afarian H. Clinical
impression and ascites appearance do not rule out bacterial peritonitis.
J. Emerg. Med. 2013; 44: 903–9.

4
Age, years
Race
Early diagnostic paracentesis (<12 h)
Antibiotic prophylaxis
Malignancy, any
Sepsis
Acute kidney injury

Exp (B)

95% CI

P value

1.080
0.723
0.420
3.332
1.715
4.872
1.704

1.02–1.142
0.317–1.652
0.188–0.938
1.123–9.823
0.654–4.498
1.976–12.012
0.659–4.408

0.006
0.442
0.034
0.030
0.273
0.001
0.272

5

6

7

CI, conﬁdence interval.
Primary independent variables are shown in italics.

retrospective, allowing for potential confounding factors in the
care of patients with SBP.
The decision to implement 12 h as the cutoff time to
deﬁne early versus late paracentesis reﬂects the standard set by
previous studies on this topic. At the same time, this time window highlights the challenges inherent to the current rubric of
decompensated cirrhosis management in the inpatient setting.
First, it necessitates a high index of suspicion in order for an
early diagnosis of SBP may be made, particularly in patients
who do not exhibit obvious vital sign instability to alert providers
to the onset of sepsis. The timely diagnosis and management of
SBP requires the recognition that a history of advanced liver disease with ascites alone is sufﬁcient to mandate paracentesis. It is
clear that clinical impression alone is inadequate to rule out a
diagnosis of SBP.17 Secondly, as many of these patients are
admitted through the emergency department and indeed may
spend the majority of their initial 12 h following hospital presentation receiving triage care in this setting, the effectiveness of this
EDP approach will require awareness and engagement of emergency department physicians. We believe this study provides a
strong basis for prospective evaluation of protocolized early
paracentesis strategies that could further establish the value of
early (or immediate) paracentesis as a standard of care for the
hospitalized cirrhotic patient with ascites.
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